Novo Nordisk says it is the world's first once-weekly basal insulin approved for clinical use, which is prescribed for the ...

Awiqli, the world's first weekly insulin, simplifies diabetes management by reducing daily injections while improving ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

A new once-weekly insulin option has arrived in India, offering a potential alternative to daily basal insulin injections for ...

Awiqli is a new insulin injection that needs to be administered only once a week. Learn from a doctor about benefits, side ...

A once-weekly insulin injection is an exciting development in diabetes care, but is it automatically better for everyone?

Danish pharma major Novo Nordisk has launched 'Awiqli' in India, a once-weekly basal insulin injection for adults with ...

Novo Nordisk has introduced Awiqli (insulin icodec) in India, the world's first once-weekly basal insulin, reducing annual ...

The new insulin, Awiqli, is cheaper than many daily insulin analogues and could ease fears of multiple injections among ...

Novo Nordisk launched Awiqli, a once-weekly insulin, in India to treat type 1 and 2 diabetes. It aims to reduce injection ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India-the world's first once-weekly bas ...

Awiqli offers adults with diabetes fewer injections while maintaining effective blood sugar control through weekly dosing.